Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Broadcom
AVGO
|
+$67.3M |
| 2 |
Veralto
VLTO
|
+$60.2M |
| 3 |
Newmont
NEM
|
+$43.4M |
| 4 |
Vertiv
VRT
|
+$19.4M |
| 5 |
Webster Financial
WBS
|
+$17.3M |
Top Sells
| 1 |
Apple
AAPL
|
+$328M |
| 2 |
Microsoft
MSFT
|
+$244M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$237M |
| 4 |
VMW
VMware, Inc
VMW
|
+$130M |
| 5 |
NVIDIA
NVDA
|
+$109M |
Sector Composition
| 1 | Technology | 30.91% |
| 2 | Healthcare | 12.91% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 9.36% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
PureCycle Technologies
PCT
$2.38B
| $851K | ﹤0.01% |
210,100
+12,200
| +6% | +$49.4K |
|
2327
Cantaloupe
CTLP
$789M
| $849K | ﹤0.01% |
114,600
-12,900
| -10% | -$95.6K |
|
2328
SoundHound AI
SOUN
$5.73B
| $849K | ﹤0.01% |
400,500
+49,000
| +14% | +$104K |
|
2329
Flushing Financial
FFIC
$465M
| $847K | ﹤0.01% |
51,423
-7,000
| -12% | -$115K |
|
2330
Tarsus Pharmaceuticals
TARS
$2.29B
| $847K | ﹤0.01% |
41,833
-7,600
| -15% | -$154K |
|
2331
CureVac
CVAC
$1.21B
| $846K | ﹤0.01% |
198,547
-22,859
| -10% | -$97.4K |
|
2332
Mission Produce
AVO
$829M
| $846K | ﹤0.01% |
83,800
-9,500
| -10% | -$95.9K |
|
2333
Cellebrite
CLBT
$4.18B
| $845K | ﹤0.01% |
97,600
-10,200
| -9% | -$88.3K |
|
2334
National Presto Industries
NPK
$784M
| $843K | ﹤0.01% |
10,500
-1,100
| -9% | -$88.3K |
|
2335
4D Molecular Therapeutics
FDMT
$324M
| $841K | ﹤0.01% |
41,500
-4,600
| -10% | -$93.2K |
|
2336
ATN International
ATNI
$235M
| $838K | ﹤0.01% |
21,500
-2,700
| -11% | -$105K |
|
|
SPWR
2337
DELISTED
SunPower Corporation Common Stock
SPWR
| $834K | ﹤0.01% |
172,600
-19,700
| -10% | -$95.2K |
|
2338
Daily Journal
DJCO
$661M
| $832K | ﹤0.01% |
+2,442
| New | +$832K |
|
2339
Vital Farms
VITL
$2.1B
| $830K | ﹤0.01% |
52,900
-9,200
| -15% | -$144K |
|
2340
Tiptree Inc
TIPT
$882M
| $825K | ﹤0.01% |
43,523
-5,000
| -10% | -$94.8K |
|
2341
Bally's
BALY
$487M
| $816K | ﹤0.01% |
58,525
-7,500
| -11% | -$105K |
|
2342
MaxCyte
MXCT
$151M
| $815K | ﹤0.01% |
173,500
-16,900
| -9% | -$79.4K |
|
2343
Sinclair Inc
SBGI
$933M
| $815K | ﹤0.01% |
62,550
-6,500
| -9% | -$84.7K |
|
2344
Ituran Location and Control
ITRN
$678M
| $812K | ﹤0.01% |
29,825
-3,500
| -11% | -$95.3K |
|
2345
TTEC Holdings
TTEC
$179M
| $810K | ﹤0.01% |
37,400
-3,800
| -9% | -$82.3K |
|
|
FNA
2346
DELISTED
Paragon 28, Inc.
FNA
| $809K | ﹤0.01% |
65,100
-6,600
| -9% | -$82K |
|
|
CDMO
2347
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $809K | ﹤0.01% |
124,400
-13,500
| -10% | -$87.8K |
|
|
TGB
2348
Taseko Mines
TGB
$1.08B
| $804K | ﹤0.01% |
572,000
-51,700
| -8% | -$72.7K |
|
2349
Vishay Precision Group
VPG
$396M
| $804K | ﹤0.01% |
23,600
-2,400
| -9% | -$81.8K |
|
2350
Arhaus
ARHS
$1.56B
| $803K | ﹤0.01% |
67,800
-6,800
| -9% | -$80.6K |
|